Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment. [electronic resource]
Producer: 20180117Description: 56-61 p. digitalISSN:- 2352-3964
- Aged
- Antineoplastic Agents, Immunological -- therapeutic use
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Humans
- Imidazoles -- therapeutic use
- Ipilimumab -- therapeutic use
- Lymphocytes -- cytology
- Male
- Melanoma -- drug therapy
- Middle Aged
- Multivariate Analysis
- Neoplasm Staging
- Neutrophils -- cytology
- Oximes -- therapeutic use
- Proportional Hazards Models
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.